Moffitt Researchers Discover Possible New Treatment Strategy for Lung Cancer

Moffitt Researchers Discover Possible New Treatment Strategy for Lung Cancer

TAMPA, Fla.  – Lung cancer is the second most common cancer found in both men and women. It is estimated there will be roughly 228,000 new lung cancer cases this year, and nearly 30% of those patients will have mutations in the KRAS pathway. This type of mutation makes the cancer more aggressive and difficult to treat. Researchers at Moffitt Cancer Center are hoping to change that. In a new study published in Cancer Research, the team discovered a new treatment approach that may help this group of patients.

Full Story

Related posts

UCF Researchers Work to Develop Cleaner-Burning, Renewable Fuels

University of Central Florida researchers are working to narrow the field of potential biofuels as…

Miami Valves 2020 Explores Innovative Cardiac Treatment Strategies

Advances in therapies for structural cardiology were highlighted at Miami Valves 2020, a three-day conference…

UCF Florida Prison Education Project to Offer Online Courses for Inmates

Research has shown that inmates who participate in correctional-education programs are 40 percent less likely…